logo

Nicholas Vogelzang, MD

Nicholas Vogelzang, MD

Hematology Las Vegas, NV

Physician

Office Address

Office Map
  • 3730 S Eastern Ave
    Las Vegas, NV 89169
    Phone: (702) 952-3400
    Fax: (702) 952-3460

Dr. Vogelzang's Clinical Specialties & Interests

  • Hematology: General Hematology

Dr. Vogelzang's Education & Medical Training

  • University of Minnesota at FairviewUniversity of Minnesota at FairviewFellowship, Medical Oncology
  • Rush University Medical CenterRush University Medical CenterFellowship, Medical Oncology
  • Rush University Medical CenterRush University Medical CenterResidency, Internal Medicine
  • U of IL Coll of MedUniversity of Illinois College of MedicineMedical School

Dr. Vogelzang's Certifications & Licensure

  • NV State Medical LicenseNV State Medical License2004 - 2015
  • American Board of Internal MedicineAmerican Board of Internal MedicineInternal Medicine, 1977
  • American Board of Internal MedicineAmerican Board of Internal MedicineMedical Oncology, 1981

Dr. Vogelzang's Awards, Honors, & Recognition

  • American Society of Clinical OncologistsFellow (FASCO)American Society of Clinical Oncologists, 2007

Dr. Vogelzang's Publications & Presentations

PubMed | Citations by Web of Science®

Grant Support

  • Zoledronate In Osteoporosis Of Prostate Cancer
    Zoledronate In Osteoporosis Of Prostate CancerNational Center For Research Resources
    2004 - 2004
  • Uccrc -Cancer Center Support Grant
    Uccrc -Cancer Center Support GrantNational Cancer Institute
    2002 - 2003
  • Core--Developmental Funds
    Core--Developmental FundsNational Cancer Institute
    2002 - 2002
  • Uccrc-Cancer Center Support Grant
    Uccrc-Cancer Center Support GrantNational Cancer Institute
    2001 - 2001
  • Pharmacokinetics Of ABT-627 In Subjects With Refractory Malignancies
    Pharmacokinetics Of ABT-627 In Subjects With Refractory MalignanciesNational Center For Research Resources
    2000 - 2002
  • Zoledronate &Osteoporotic Effects Of Androgen Deprivati
    Zoledronate &Osteoporotic Effects Of Androgen DeprivatiNational Center For Research Resources
    2000 - 2002
  • Uccrc--Cancer Center Support Grant
    Uccrc--Cancer Center Support GrantNational Cancer Institute
    1999 - 2001
  • Phase I Study Of Cep-2563 Dihydrochloride In Adults With Solid Tumors
    Phase I Study Of Cep-2563 Dihydrochloride In Adults With Solid TumorsNational Center For Research Resources
    1998 - 2000
  • Prostate Cancer
    Prostate CancerNational Cancer Institute
    1996 - 2001
  • Phase I Trial Of Ct-1501r And High Dose IL-2 In Renal Cancer Or Melanoma
    Phase I Trial Of Ct-1501r And High Dose IL-2 In Renal Cancer Or MelanomaNational Center For Research Resources
    1995 - 1995
  • Effect Of Food And Comparative Bioavailability Of Oral Bropirimine In Cancer
    Effect Of Food And Comparative Bioavailability Of Oral Bropirimine In CancerNational Center For Research Resources
    1994 - 1995
  • Phase I Trial Of Ct-1501r And High Dose IL 2 In Renal Cancer Or Melanoma
    Phase I Trial Of Ct-1501r And High Dose IL 2 In Renal Cancer Or MelanomaNational Center For Research Resources
    1994 - 1994
  • Cancer And Leukemia Group B
    Cancer And Leukemia Group BNational Cancer Institute
    1993 - 1998
  • Cancer And Leukemia
    Cancer And LeukemiaNational Cancer Institute
    1989 - 1992
  • Cancer And Leukemia Group B Grant Application
    Cancer And Leukemia Group B Grant ApplicationNational Cancer Institute
    1988 - 1988

Dr. Vogelzang's Professional Memberships

Insurance Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • First Health PPO
  • Great West PPO
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PPO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO

Physicians, view Dr. Vogelzang's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV